Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

With GRANULES's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 0.00000
forwardPE 19.04472
debtToEquity 32.01400
earningsGrowth -0.06400
revenueGrowth -0.01500
grossMargins 0.58152
operatingMargins 0.15266
trailingEps 19.73000
forwardEps 0.00000

GRANULES's Forward PE ratio is favorable, indicating that the stock price is well-positioned in relation to its earnings. It is not overpriced, leaving room for growth, which makes it a solid option for investors seeking both stability and future appreciation.
Granules India Limited's low growth in both earnings and revenue indicates potential profit shrinkage. This downward trend could be a sign of weakening financial health, signaling challenges for the company's future profitability.
With negative gross and operating margins, GRANULES is facing losses at both the production and operational levels. This signals significant financial strain and may indicate that the company is struggling to manage costs effectively.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

The current valuation of Granules India Limited, concerning its projections, presents no apparent risks or opportunities. This neutral outlook may lead investors to adopt a cautious approach as they await further insights into the company's performance.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


Analysts have shown a buy bias for GRANULES, marking it as a favorable investment option. This could inspire investors to see GRANULES as a strong place to park their money, given the positive outlook and growth potential associated with the stock in recent evaluations.